The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so semiglutide is a pure glp-1 Agonist um to be more clear it is um it has even a it has a I I would say a sort of comparable um Affinity to Pure uh glp1 so one way that we do that there's a you know sort of a chemical way that you can look at the concentration of semi-glutide and ask the question how much of it do you need to replicate the effect of you know pure glp1 and in the case of semi-glutide you know it's on the order of you know half as potent
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.